US 8691831
Heterocyclic aspartyl protease inhibitors
granted A61KA61K31/4168A61K31/4178
Quick answer
US patent 8691831 (Heterocyclic aspartyl protease inhibitors) held by Pharmacopeia Drug Discovery, Inc. expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4168, A61K31/4178, A61P, A61P25/00